先进医疗设备公司iRhythm Technologies(IRTC)30日发布2024财年第三季度财报,业绩数据令市场失望,公司股价盘前大跌9.98%。
财报显示,iRhythm第三季度每股亏损高达1.26美元,远超分析师预期的每股亏损57美分。公司营收同比增长18.4%至1.4754亿美元,但也未达到华尔街1.4673亿美元的预期水准。
第三季度亏损扩大至4618万美元,这一亏损规模在市场难以预料之外。尽管iRhythm公司的产品和服务需求保持强劲,但成本管控不利和运营效率较低导致利润大幅下滑。投资者们对公司业绩前景产生担忧,纷纷抛售公司股票,致使股价遭遇重挫。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.